Kumar Neil

EDGAR CIK 0001742485

Bridgebio Pharma, Inc. - BBIO

CEO Director
Chief Executive Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($613,826)
-27,389 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
4
($27.07) M
-750,000 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/25/2025
10b5-1
03/27/2025
Sell
-75,000 @ $36.87
($2,764,943) 4,948,447 (-1.49%) Indirect - By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
02/25/2025
10b5-1
02/27/2025
Sell
-75,000 @ $33.57
($2,517,971) 5,023,447 (-1.47%) Indirect - By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
01/29/2025
10b5-1
01/30/2025
Sell
-273,068 @ $36.35
($9,925,269) 5,098,447 (-5.08%) Indirect - By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
01/28/2025
10b5-1
01/30/2025
Sell
-326,932 @ $36.29
($11,863,381) 5,371,515 (-5.74%) Indirect - By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
11/19/2024
10b5-1
11/20/2024
Sell
-27,389 @ $22.41
($613,826) 4,897,443 (-0.56%) Direct